Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.39 HKD
−193.19 M HKD
681.78 K HKD
533.76 M
About BRII BIOSCIENCES L
Sector
CEO
Zhi Hong
Website
Headquarters
Haidian
Founded
2017
FIGI
BBG011MPQG39
Brii Biosciences Ltd. engages in advancing therapies for significant infectious diseases and other illnesses which have significant public health burdens. The firm also focuses on developing therapies for infectious diseases and central nervous system diseases. The company was founded by Zhi Hong on December 8, 2017, and is headquartered in Beijing, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 2137 is 0.85 HKD — it has decreased by −6.82% in the past 24 hours. Watch BRII BIOSCIENCES L stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange BRII BIOSCIENCES L stocks are traded under the ticker 2137.
2137 stock has fallen by −13.68% compared to the previous week, the month change is a −24.77% fall, over the last year BRII BIOSCIENCES L has showed a −62.22% decrease.
2137 reached its all-time high on Sep 21, 2021 with the price of 52.60 HKD, and its all-time low was 0.85 HKD and was reached on Apr 19, 2024. View more price dynamics on 2137 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
2137 stock is 4.76% volatile and has beta coefficient of 1.59. Track BRII BIOSCIENCES L stock price on the chart and check out the list of the most volatile stocks — is BRII BIOSCIENCES L there?
Today BRII BIOSCIENCES L has the market capitalization of 643.54 M, it has decreased by −4.26% over the last week.
Yes, you can track BRII BIOSCIENCES L financials in yearly and quarterly reports right on TradingView.
BRII BIOSCIENCES L is going to release the next earnings report on Mar 21, 2025. Keep track of upcoming events with our Earnings Calendar.
2137 earnings for the last half-year are −0.41 HKD per share, whereas the estimation was −0.37 HKD, resulting in a −11.76% surprise. The estimated earnings for the next half-year are −0.25 HKD per share. See more details about BRII BIOSCIENCES L earnings.
2137 net income for the last half-year is −303.99 M HKD, while the previous report showed 16.30 M HKD of net income which accounts for −1.96 K% change. Track more BRII BIOSCIENCES L financial stats to get the full picture.
No, 2137 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 18, 2024, the company has 128.00 employees. See our rating of the largest employees — is BRII BIOSCIENCES L on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BRII BIOSCIENCES L EBITDA is −561.24 M HKD, and current EBITDA margin is −94.71 K%. See more stats in BRII BIOSCIENCES L financial statements.
Like other stocks, 2137 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BRII BIOSCIENCES L stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BRII BIOSCIENCES L technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BRII BIOSCIENCES L stock shows the strong sell signal. See more of BRII BIOSCIENCES L technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.